Hindustan TimesLean L·
Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs
Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life
Read at Hindustan Times →
